Personalized Medicine at FDA: 2015 Progress Report.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 49
- By:
- Publication type:
- Article
Works matching IS 21660166 AND DT 2016 AND VI 5 AND IP 1
Results: 24
1
2
The Coming Government Takeover of Drug Pricing.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 47
- By:
- Publication type:
- Article
3
Liquid Biopsy Characterizing CTCs Can Aid in Treatment Selection.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 46
- By:
- Publication type:
- Article
4
Omit Chemotherapy for Premenopausal Luminal A Breast Cancer?
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 44
- By:
- Publication type:
- Article
5
Early Results with Immunotherapy in Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 43
- Publication type:
- Article
6
ESR1 Mutations Portend Worse Survival in ER+ Advanced Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 42
- By:
- Publication type:
- Article
7
Promising Combo in Elderly Patients with ALL.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 41
- Publication type:
- Article
8
Pembrolizumab Shows Promise in Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 40
- By:
- Publication type:
- Article
9
Rituximab Boosts Chemotherapy Benefit in B-Cell Precursor ALL.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 39
- Publication type:
- Article
10
Nilotinib Yields Better Rates of Molecular Response Than Imatinib in the Frontline Setting.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 38
- Publication type:
- Article
11
Midostaurin: First Targeted Therapy in AML Is Potentially Practice Changing.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 37
- Publication type:
- Article
12
In Newly Diagnosed Myeloma Patients, Triplets Preferred.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 36
- By:
- Publication type:
- Article
13
Idelalisib Combined with Bendamustine/Rituximab Boosts Survival in CLL.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 35
- By:
- Publication type:
- Article
14
Ibrutinib a New Standard of Care for Elderly CLL Patients.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 34
- Publication type:
- Article
15
Checkpoint Inhibitors in Lymphoma: A New Universe.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 33
- By:
- Publication type:
- Article
16
CAR T-Cell Therapy Highly Active in Various Hematologic Malignancies.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 32
- By:
- Publication type:
- Article
17
Venetoclax: Strong Showing in CLL.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 31
- By:
- Publication type:
- Article
18
Another Study Shows Benefit with a Pediatric Regimen in Young Adults with ALL.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 30
- By:
- Publication type:
- Article
19
Inherited Prostate Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 28
- By:
- Publication type:
- Article
20
Case: Clinically Node-Negative Merkel Cell Carcinoma.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 27
- Publication type:
- Article
21
Human Epidermal Growth Factor Receptor Type 2 Therapy in Gastrointestinal Tumors.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 20
- By:
- Publication type:
- Article
22
BRAF Mutation in Colorectal Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 14
- By:
- Publication type:
- Article
23
Cancer Stem Cell Research: A New Frontier in the Fight Against Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 8
- Publication type:
- Article
24
On the Cutting Edge of Personalizing Care: From Molecular Tumor Boards to Cancer Stem Cell Research.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 7
- By:
- Publication type:
- Article